<qa>  What is the primary objective of this study?The primary objectives of this study are to determine the maximum tolerated dose MTD or optimal biologic dose OBD and safety profile of CAT-8015 in subjects with relapsed or refractory advanced B-cell NHL DLBCL, FL, MCL or CLL. 